# A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis

> **NCT06108024** · PHASE2 · RECRUITING · sponsor: **DermBiont, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Seborrheic Keratosis

## Interventions

- **DRUG:** SM-020 gel 1.0%
- **DRUG:** Vehicle gel

## Key facts

- **NCT ID:** NCT06108024
- **Lead sponsor:** DermBiont, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-06
- **Primary completion:** 2024-09-15
- **Final completion:** 2024-10-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06108024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06108024, "A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06108024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*